USP17LA loss enhances T-cell function and anti-tumor activity in murine tumor models. Usp17la-deficient T cells exhibit ...

A new study on rheumatoid arthritis has found that while individuals look and feel healthy in the years before their symptoms ...

Scientists have uncovered how a key type of immune cell adapts its behavior depending on the type of infection, paving the way for better vaccines and advancing research into immune-related diseases.

From the moment they're born, newborns—or, specifically, their immune systems—must learn to fight germs without harming their own tissues.

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer.

David Baker’s Nobel Prize-winning lab has designed protein on/off switches as a tool for tunable cancer immunotherapies and biosensors.

An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...

KEYTRUDA ® is a registered trademark of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. and the company is not affiliated with HCWB.

Autoimmune disease is an unrelenting attack of the body on itself. Drugs that suppress the immune system quell the attack for a while, but patients need to keep taking these medicines, putting them at ...